other material
confidence high
sentiment positive
materiality 0.50
bioAffinity Technologies announces Mexican patent allowance for CyPath Lung cancer detection method
bioAffinity Technologies, Inc.
- Mexican patent allowance for flow-cytometry methods to detect lung cancer using CyPath Lung.
- Patent will protect use of defined antibodies and TCPP porphyrin to label sputum cells.
- CyPath Lung demonstrated 92% sensitivity, 87% specificity, 88% accuracy, 99% NPV in trial.
- IP portfolio now includes patents in US, EU, China, Japan, Australia, Canada, and Mexico.